ALK
ALK (anaplastic lymphoma kinase) is a member of insulin receptor protein-tyrosine superfamily, functioning in embryonic development and involved in cell survival and cell fate.
- A8251 TAE684 (NVP-TAE684)Summary: ALK inhibitor,potent and selective
- A5602 SB525334Summary: (TGF-beta1) receptor inhibitor
- A1367 ALK-IN-1Summary: Anaplastic lymphoma kinase (ALK) inhibitor
- A8324 LDN-193189Target: BMP and Other Activin ReceptorsSummary: ALK inhibitor,potent and selective
- A8328 LDK378Target: ALKSummary: Potent ALK inhibitor
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: IGF-IR/IR/ALK inhibitor, ATP-competitive
- A8393 CH5424802Target: ALKSummary: ALK inhibitor,potent and ATP-competitive
- A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R inhibitor
- B4882 PF-06463922Target: ALK|ROS1Summary: ALK/ROS1 inhibitor,potent and selective
- B4842 LDN-214117Summary: potent and selective ALK2 inhibitor